Aligos Therapeutics, Inc. (ALGS) Net income 2019–2025
Aligos Therapeutics, Inc. (ALGS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$24.2MFY2025 · since FY2019: -$52.3M → -$24.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$24.2M | +81.6% |
| FY2024 | -$131.2M | -49.6% |
| FY2023 | -$87.7M | +8.7% |
| FY2022 | -$96.0M | +25.2% |
| FY2021 | -$128.3M | -18.2% |
| FY2020 | -$108.5M | -107.7% |
| FY2019 | -$52.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ALGS financial trends
ALGS RevenueALGS Net marginALGS Gross profitALGS Gross marginALGS Operating incomeALGS Operating marginALGS Operating cash flowALGS Free cash flowALGS Capital expendituresALGS Return on equityALGS Stock buybacksALGS Dividends paidALGS Total assetsALGS Total liabilitiesALGS Shareholders’ equityALGS overview →